Home›Companies›Healthcare›PrognomIQ

PrognomIQ, Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 16, 2026·Suggest an edit

About PrognomIQ

PrognomIQ is a private company based in San Mateo, California. It has reported $56,237,532 raised in three offerings on Form D since August 2024. Its chief executive is Philip Ma, Ph.D..

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 2, 2026Jan 16, 2026$11,872,784fully sold6$1.9MEquityRule 506(b)Form D ↗
Aug 1, 2025Aug 11, 2025$10,049,366fully sold9$1.1MEquity, Options, Securities on exerciseRule 506(b)Form D ↗
Aug 12, 2024Aug 26, 2024$34,315,382fully sold10$3.4MEquity, Options, Securities on exerciseRule 506(b)Form D ↗
Total, three offerings$56,237,532

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on PrognomIQ's Form D filed Jan 16, 2026.

BD
Brian Koh, M.D.
Executive officer
BD
Bruce Wilcox, Ph.D.
Executive officer
ID
DS
David Siewers
Executive officer
PD
Philip Ma, Ph.D.
Chief Executive Officer and director

Earlier filings also listed Joel Kaufman (executive officer, last listed Aug 2025), Rajesh Garg (director, last listed Aug 2024) and Isaac Ro (director, last listed Aug 2024).

Sources

  1. SECPrognomIQ, Inc. filing history